According to their Press Release, The National Institutes of Health (NIH) awarded Chlamydia researchers at The South Texas Center for Emerging Infectious Diseases (STCEID) at The University of Texas at San Antonio (UTSA) a $1.8 million grant over the next five years to study the pathogenesis of Chlamydia trachomatis, the bacterium that causes human genital Chlamydia.
By studying this sexually transmitted disease, UTSA can better serve the pharmaceutical industry and work together to eradicate Chlamydia from the world's population.
Do you think this was a proper use of NIH funds? What other research are you seeing in this arena?
About:
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is an extension of the Partnerships in Clinical Trials Conference.
As a reader of the Partnerships in Clinical Trials blog, mention code XP1718BLOG when registering to join us in Sao Paulo for Partnerships in Clinical Trials Latin America to receive a discount of $100 off the current rate!
Would you like to guest blog on our site? Or send us feedback? Send an email to jpereira@iirusa.com.



.gif)
0 comments:
Post a Comment